Sign In
Buy HOLX
$76.01
+0 (+0%)
At Close: Jul 06, 2026
Expert Ratings for Hologic
03:14pm, Tuesday, 17'th May 2022 Benzinga
Analysts have provided the following ratings for Hologic (NASDAQ:HOLX) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
0
3
3
0
0
Last 30
CNBC's Final Trades: Charles Schwab And These 3 Medical Stocks
11:52am, Thursday, 12'th May 2022 Benzinga
On CNBC’s “Halftime Report Final Trades,” Karen Firestone of Aureus Asset Management said Charles Schwab Corporation (NYSE: SCHW) is trading at 14 times next year’s earnings. “If rates go u
Final Trades: Charles Schwab, Merck, Hologic & more
01:53pm, Wednesday, 11'th May 2022
The "Halftime Report" traders give their top picks to watch for the second half.
Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know
01:00pm, Wednesday, 11'th May 2022 Zacks Investment Research
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know
10:32am, Wednesday, 11'th May 2022
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Raymond James Maintains Outperform Rating for Hologic: Here's What You Need To Know
04:01pm, Thursday, 28'th Apr 2022 Benzinga
Raymond James has decided to maintain its Outperform rating of Hologic (NASDAQ:HOLX) and lower its price target from $84.00 to $83.00.
Shares of Hologic are trading down 2.08% over the last 24 hours,
Lower COVID-19 Assay Sales Weighs On Hologic's Q2 Revenue
03:27pm, Thursday, 28'th Apr 2022
Hologic Inc (NASDAQ: HOLX) reported Q2 FY22 sales of $1.44 billion, down 7% Y/Y, and beating the consensus Wall Street estimate for revenues of $1.29 billion. Lower sales of COVID-19 assays primaril
Hologic (HOLX) Q2 Earnings Surpass Estimates, 2022 View Up
12:47pm, Thursday, 28'th Apr 2022
Hologic's (HOLX) second-quarter 2022 revenues decline year over year primarily due to lower COVID-19 assay sales compared to the prior year.
Chip shortage ‘impacts women's health': Hologic CEO
12:06pm, Thursday, 28'th Apr 2022
Steve MacMillan, the CEO of medical technology company Hologic, warned that the global semiconductor chip shortage “impacts women's health.”
Hologic (HOLX) Q2 2022 Earnings Call Transcript
01:30am, Thursday, 28'th Apr 2022 The Motley Fool
HOLX earnings call for the period ending March 31, 2022.
Hologic, Inc. (HOLX) CEO Steve MacMillan on Q2 2022 Results - Earnings Call Transcript
11:23pm, Wednesday, 27'th Apr 2022
Hologic, Inc. (NASDAQ:HOLX ) Q2 2022 Earnings Conference Call April 27, 2022 4:30 PM ET Company Participants Ryan Simon - Vice President, Investor Relations Steve MacMillan - Chairman, President and C
Hologic (HOLX) Q2 Earnings and Revenues Surpass Estimates
09:15pm, Wednesday, 27'th Apr 2022 Zacks Investment Research
Hologic (HOLX) delivered earnings and revenue surprises of 33.55% and 12.60%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Hologic (HOLX) Q2 Earnings and Revenues Surpass Estimates
06:19pm, Wednesday, 27'th Apr 2022
Hologic (HOLX) delivered earnings and revenue surprises of 33.55% and 12.60%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for Hologic (HOLX) This Earnings Season?
11:31am, Tuesday, 26'th Apr 2022 Zacks Investment Research
Hologic (HOLX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Is a Surprise Coming for Hologic (HOLX) This Earnings Season?
09:02am, Tuesday, 26'th Apr 2022
Hologic (HOLX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
